LJI Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
LJI Wealth Management's BMY Position: Q1 2026 in Review
LJI Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 3.8% in Q1 2026, selling an estimated $86.9K and leaving 37,598 shares worth $2.28M. The position accounts for 0.36% of the portfolio, ranked #28.
LJI Wealth Management first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- LJI Wealth Management held 37,598 shares of Bristol-Myers Squibb worth $2.28M as of Q1 2026.
- LJI Wealth Management sold 1,490 Bristol-Myers Squibb shares in Q1 2026, an estimated $86.9K.
- Bristol-Myers Squibb made up 0.36% of LJI Wealth Management's portfolio in Q1 2026, its #28 holding.
- LJI Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on LJI Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.